Skip to main content
Premium Trial:

Request an Annual Quote

Canadian Team Sequencing SARS Virus

NEW YORK, April 9 - Scientists from the Genome Science Center at the British Columbia Cancer Agency are sequencing the SARS virus, and expect to have a completed viral genome within as little as two weeks, Canadian newspapers have reported.

 

At least 30 genome researchers are involved in the project, which is being led by virologist Caroline Astell, according to a report in the Ottawa Citizen.

 

Early identifications using electron microscopy, PCR, and even a viral microarray have identified the SARS virus as a coronavirus, and the Lancet reported a study confirming these results today. But Astell told the Toronto Globe and Mail yesterday that "only 50 to 60 percent" was anything like known coronaviruses.

 

This sequencing project is part of the overall global push to nail down the biological etiology and mechanisms of a pathogen that has led to over 2,000 cases of Severe Acute Respiratory Syndrome since it was first reported in Southern Chinaand Hong Kongin late March. Labs in over 11 countries are contributing to this effort, according to press reports.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.